Experience in the use of pharmacogenetic testing for personalizing warfarin dosing in outpatient conditions
Abstract
About the Authors
E. V. GavrisyukRussian Federation
D. A. Sychev
Russian Federation
R. E. Kazakov
Russian Federation
A. V. Kossovskaya
Russian Federation
V. F. Marinin
Russian Federation
References
1. Антонов И.М., Аристов Е.Г., Сычев Д.А. [и др.] Антикоа-гулянтные клиники: зарубежный опят и перспективы для Российского здравоохранения // Креативная кардиология. 2010. № 1. С. 35-41.
2. Клиническая фармакогенетика / Сычев Д.А., Раменская Г.В., Игнатьев И.В., Кукес В.Г. М.: ГЭОТАР-Медиа, 2007. 50 с.
3. Conen D., Osswald S., Albert C. Epidemiology of atrium fibrillation. // Swiss Medical Weekly. 2009. Vol. 139. P. 346-352.
4. Ederhy S., Cohen A. Optimising stroke prevention in non-valvular atrial fibrillation // Expert Opin. Pharmacother. 2006. Vol. 7, No. 15. P. 2079-2094.
5. Epstein R.S., Moyer T.P., Aubert R.E. [et al.] Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study) // J. Am. Coll. Cardiol. 2010. Vol. 55, No. 25. P. 2804-2812.
6. Fihn S.D., McDommel M., Matin D. [et al.] Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group // Ann. Intern. Med. 1993. Vol. 118. No. 7. P. 511-520.
7. Gage B.F., Eby C.S. Pharmacogenetics and anticoagulant therapy // J. Thromb. Thrombolysis. 2003. Vol. 16, No. 1-2. P. 73-78.
8. Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis antithrombotic therapy to prevent stroke in patient who have non-valvulal atrial fibrillation // Ann. Intern. Med. 2007. Vol. 146. P. 857-867.
9. Hylek E.M., Chang Y., Jensvold N. [et al.] Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation // N. Eng. J. Med. 2003. Vol. 349. P. 1019-1026.
10. Radaelli F., Paggi S., Terruzzi V [et al.] Management of warfarin associated coagulopathy in patients with acute gastrointestinal bleeding: A cross-sectional physician survey of current practice // Ann. Parmacoter. 2010. Vol. 44, No. 7-8. P. 1152-1157.
11. Winans A.R., Rudd K.M., Triller D. Assessing anticoagulation knowledge in patients new to warfarin therapy // Ann. Parmacother. 2010. Vol. 44, No. 7-8. P. 1152-1157.
Review
For citations:
Gavrisyuk E.V., Sychev D.A., Kazakov R.E., Kossovskaya A.V., Marinin V.F. Experience in the use of pharmacogenetic testing for personalizing warfarin dosing in outpatient conditions. Pacific Medical Journal. 2015;(1):60-62. (In Russ.)